Skip to content

Form 4 filed by Hohl Benjamin

Hohl Benjamin filed this Form 4 on ELVN (Enliven Therapeutics, Inc.) with 3 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-21 21:53:41 UTC.

Accession
0001882764-26-000009
Filed
2026-10-21
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: ELVN · Enliven Therapeutics, Inc. (CIK 1672619)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-10-19M exercised+6,018$14.8544,018D
Common Stock 2026-10-19S sold-6,018$38.475538,000D
Stock Option (right to buy) derivative2026-10-19M exercised-6,018$0175,000D